darunavir/cobicistat/emtricitabine/tenofovir alafenamide

darunavir/cobicistat/emtricitabine/tenofovir alafenamide is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
da-roo-na-veer/koe-bik-i-stat/em-tri-si-ti-been/te-noe-fo-veer al-a-fen-a-mide

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Symtuza

Ther. Class.

antiretrovirals

pharmacoenhancers

Pharm. Class.

protease inhibitors

enzyme inhibitors

nucleoside reverse transcriptase inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
da-roo-na-veer/koe-bik-i-stat/em-tri-si-ti-been/te-noe-fo-veer al-a-fen-a-mide

To hear audio pronunciation of this topic, purchase a subscription or log in.

Trade Name(s)

  • Symtuza

Ther. Class.

antiretrovirals

pharmacoenhancers

Pharm. Class.

protease inhibitors

enzyme inhibitors

nucleoside reverse transcriptase inhibitors

There's more to see -- the rest of this topic is available only to subscribers.